论文部分内容阅读
目的探讨西药药剂头孢米诺的临床应用。方法收集2013年1月~2014年12月我院收治的82例呼吸道感染患者和75例泌尿系感染患者,共157例患者的临床资料。所有患者均采用头孢米诺治疗,观察记录两组患者的临床疗效和不良反应发生情况。结果下呼吸道感染患者痊愈率68.3%,总有效率为92.7%;泌尿系感染痊愈率66.7%,总有效率为90.7%。下呼吸道感染患者发生不良反应4例;泌尿系感染患者出现不良反应3例。结论头孢米诺治疗呼吸道感染和泌尿系感染疗效确切,杀菌效果显著,但是易发生过敏等不良反应,治疗过程中应密切注意。
Objective To investigate the clinical application of western medicine cefmenoximab. Methods The clinical data of 82 patients with respiratory tract infection and 75 patients with urinary tract infection in our hospital from January 2013 to December 2014 were collected. A total of 157 patients were enrolled. All patients were treated with cefmenodone, observed and recorded two groups of patients with clinical efficacy and adverse reactions. Results The cure rate of lower respiratory tract infection was 68.3%, the total effective rate was 92.7%. Urinary tract infection cure rate was 66.7%, the total effective rate was 90.7%. Adverse reactions in patients with lower respiratory tract infection in 4 cases; urinary tract infections in patients with adverse reactions in 3 cases. Conclusion Cefminox treatment of respiratory tract infection and urinary tract infection is effective, bactericidal effect is significant, but prone to allergic and other adverse reactions, the treatment should pay close attention.